Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Chemed Corp Lowers FY 2013 EPS Guidance


Monday, 28 Oct 2013 04:02pm EDT 

Chemed Corp announced that for fiscal 2013, it expects earnings per diluted share, excluding non-cash expense for stock options, the non-cash interest expense related to the accounting for convertible debt, litigation and other discrete items, will be in the range of $5.60 to $5.65. According to I/B/E/S Estimates, analysts were expecting the Company to report EPS of $5.67 for fiscal 2013. 

Company Quote

106.82
0.66 +0.62%
26 Dec 2014